Eli Lilly & Hims & Hers Health announce agreement to expand access to Zepbound & Foundayo
HIMS•Eli Lilly and Hims & Hers Health announced an agreement to offer FDA-approved Zepbound and Foundayo through the Hims & Hers platform at self-pay prices starting at $299 and $149 per month, respectively. Hims & Hers committed not to offer compounded copies of Lilly’s GLP-1 drugs in the future.
1. Agreement and pricing
The companies said the agreement will give patients access to the FDA-approved treatments through the Hims & Hers platform at self-pay prices starting at $149 per month for Foundayo and $299 per month for Zepbound. Hims & Hers committed not to offer compounded copies of Lilly’s GLP-1 drugs in the future.
